# InMed receives Nasdaq notice over equity requirement — retained record

> Retained news record from news:seeking-alpha.

Canonical: https://highsignal.app/data/records/81046bad96b22de7

[← sources](https://highsignal.app/data)


source: [news](https://highsignal.app/data/news) (news:seeking-alpha)  published 2026-09-18 21:47 ingested 2026-09-19 02:57

[original source ↗](https://seekingalpha.com/news/4644551-inmed-receives-nasdaq-notice-over-equity-requirement?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news)

## retained text



```
Search fieldHome page Seeking Alpha - Power to InvestorsAbout PremiumCreate free accountSearch for Symbols, analysts, keywordsLog in

InMed receives Nasdaq notice over equity requirement

Sep 18, 2026, 5:47 PM ETInMed Pharmaceuticals Inc. (INM) StockBy : Pratyush Thakur, SA News Editor

InMed Pharmaceuticals (INM) said on Friday it received a Nasdaq notice after reporting shareholders' equity of $1.08M, below the $2.5M minimum required for continued listing.

The company has 45 days to submit a compliance plan. It expects its planned merger with Mentari Therapeutics and related financing to restore compliance.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Search fieldEntering text into the input field will update the search result below

Recommended For You
```



document fetched 2026-09-19 02:57 · canonical https://seekingalpha.com/news/4644551-inmed-receives-nasdaq-notice-over-equity-requirement?feed_item_type=news